CUSIP: 45773HAB8
What is CUSIP 45773HAB8?
CUSIP 45773HAB8 identifies 45773HAB8 - INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 45773HAB8:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q1 | $0 | $0 | -$15,353,842 | 0 | |
| 2023 Q4 | $16,415,000 | $15,353,842 | 93.66% | 3 | |
| 2023 Q3 | $16,415,000 | $15,194,652 | 92.25% | 3 | |
| 2023 Q2 | $16,415,000 | $14,604,742 | 92.31% | 3 | |
| 2023 Q1 | $16,415,000 | $12,825,056 | 78.52% | 3 | |
| 2022 Q4 | $16,415,000 | $14,682,472 | -$820 | 89.45% | 3 |
| 2022 Q3 | $16,415,000 | $15,140,000 | -$28,239 | 90.56% | 3 |
| 2022 Q2 | $16,415,000 | $13,258,000 | 91.32% | 3 | |
| 2022 Q1 | $16,415,000 | $16,378,000 | 94.79% | 3 | |
| 2021 Q4 | $16,415,000 | $19,526,000 | -$339,090 | 118.5% | 3 |
| 2021 Q3 | $16,010,000 | $23,355,000 | +$1,849,000 | 143.62% | 4 |
| 2021 Q2 | $15,190,000 | $26,601,000 | 175.16% | 3 | |
| 2021 Q1 | $16,415,000 | $29,105,000 | +$156,965 | 175.16% | 4 |
| 2020 Q4 | $16,415,000 | $27,114,000 | -$100,449,000 | 165.54% | 5 |
| 2020 Q3 | $59,415,000 | $135,076,000 | -$74,079,452 | 215.66% | 8 |
| 2020 Q2 | $62,500,000 | $312,090,000 | -$32,691,704 | 499.44% | 11 |
| 2020 Q1 | $75,623,000 | $111,636,000 | +$111,636,000 | 148.67% | 15 |